|
Delayed
Nasdaq
01:30:00 05/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 18.95 USD | -0.84% |
|
+1.83% | +10.33% |
| 02/09 | Omeros Insider Sold Shares Worth $929,668, According to a Recent SEC Filing | MT |
| 29/08 | Omeros Insider Sold Shares Worth $282,094, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 137.18Cr | - | - | - | - | |
| 6.8TCr | |||||
| 6.49TCr | |||||
| 2.76TCr | - | ||||
| 2.61TCr | - | ||||
| 2.57TCr |
- Stock Market
- Stocks
- OMER Stock
- Charts Omeros Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
